Qube Research & Technologies (QRT)’s Applied Therapeutics APLT Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio APLT Stock Details APLT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,167,269	Closed	-$706K	–	3656
2025 Q3	$706K	Sell	1,167,269 -655,300	-36%	-$309K	﹤0.01%	2627
2025 Q2	$567K	Sell	1,822,569 -116,435	-6%	-$45K	﹤0.01%	2652
2025 Q1	$948K	Sell	1,939,004 -11,517	-0.6%	-$6.78K	﹤0.01%	2293
2024 Q4	$1.67M	Buy	1,950,521 +1,938,161	+15,681%	+$12.1M	﹤0.01%	1956
2024 Q3	$105K	Sell	12,360 -137,635	-92%	-$811K	﹤0.01%	2741
2024 Q2	$700K	Sell	149,995 -309,146	-67%	-$1.46M	﹤0.01%	2022
2024 Q1	$3.12M	Buy	459,141 +265,468	+137%	+$1.19M	﹤0.01%	1497
2023 Q4	$649K	Buy	193,673 +186,123	+2,465%	+$463K	﹤0.01%	2153
2023 Q3	$18.8K	Buy	+7,550	New	+$12.4K	﹤0.01%	3166
2022 Q4	–	Sell	-15,060	Closed	-$14K	–	2439
2022 Q3	$14K	Sell	15,060 -2,310	-13%	-$2.77K	﹤0.01%	2333
2022 Q2	$16K	Buy	+17,370	New	+$28.4K	﹤0.01%	2287

Other funds holding APLT

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

DAM

Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Qube Research & Technologies (QRT)'s APLT Position: Q4 2025 in Review

Qube Research & Technologies (QRT) sold out of Applied Therapeutics (APLT) in Q4 2025, closing a stake of 1,167,269 shares — an estimated $706K sold.

Qube Research & Technologies (QRT) first reported a position in APLT in Q2 2022 and held it in 11 quarters. The position peaked at $3.12M in Q1 2024. 52 funds tracked by Wall St. Rank hold APLT as of Q4 2025.

Qube Research & Technologies (QRT) reported no remaining Applied Therapeutics position as of Q4 2025 after selling out during the quarter.
Qube Research & Technologies (QRT) sold 1,167,269 Applied Therapeutics shares in Q4 2025, an estimated $706K.
Qube Research & Technologies (QRT) first reported a position in Applied Therapeutics in Q2 2022 and held it in 11 quarters.
Qube Research & Technologies (QRT)'s Applied Therapeutics position peaked at $3.12M in Q1 2024.
52 funds tracked by Wall St. Rank held Applied Therapeutics as of Q4 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2025, filed 17 Feb 2026.